Looft Torey, Allen Heather K, Cantarel Brandi L, Levine Uri Y, Bayles Darrell O, Alt David P, Henrissat Bernard, Stanton Thaddeus B
Food Safety and Enteric Pathogens Research Unit, National Animal Disease Center, Agricultural Research Service, United States Department of Agriculture, Ames, IA, USA.
Baylor Institute for Immunology Research, Baylor Healthcare system, Dallas, TX, USA.
ISME J. 2014 Aug;8(8):1566-76. doi: 10.1038/ismej.2014.12. Epub 2014 Feb 13.
Disturbance of the beneficial gut microbial community is a potential collateral effect of antibiotics, which have many uses in animal agriculture (disease treatment or prevention and feed efficiency improvement). Understanding antibiotic effects on bacterial communities at different intestinal locations is essential to realize the full benefits and consequences of in-feed antibiotics. In this study, we defined the lumenal and mucosal bacterial communities from the small intestine (ileum) and large intestine (cecum and colon) plus feces, and characterized the effects of in-feed antibiotics (chlortetracycline, sulfamethazine and penicillin (ASP250)) on these communities. 16S rRNA gene sequence and metagenomic analyses of bacterial membership and functions revealed dramatic differences between small and large intestinal locations, including enrichment of Firmicutes and phage-encoding genes in the ileum. The large intestinal microbiota encoded numerous genes to degrade plant cell wall components, and these genes were lacking in the ileum. The mucosa-associated ileal microbiota harbored greater bacterial diversity than the lumen but similar membership to the mucosa of the large intestine, suggesting that most gut microbes can associate with the mucosa and might serve as an inoculum for the lumen. The collateral effects on the microbiota of antibiotic-fed animals caused divergence from that of control animals, with notable changes being increases in Escherichia coli populations in the ileum, Lachnobacterium spp. in all gut locations, and resistance genes to antibiotics not administered. Characterizing the differential metabolic capacities and response to perturbation at distinct intestinal locations will inform strategies to improve gut health and food safety.
有益肠道微生物群落的紊乱是抗生素的一种潜在附带效应,抗生素在动物养殖中有着多种用途(疾病治疗或预防以及提高饲料效率)。了解抗生素对不同肠道部位细菌群落的影响对于充分认识饲料中添加抗生素的益处和后果至关重要。在本研究中,我们定义了来自小肠(回肠)、大肠(盲肠和结肠)以及粪便的肠腔和黏膜细菌群落,并表征了饲料中添加抗生素(金霉素、磺胺二甲嘧啶和青霉素(ASP250))对这些群落的影响。对细菌组成和功能进行的16S rRNA基因序列和宏基因组分析揭示了小肠和大肠部位之间存在显著差异,包括回肠中厚壁菌门和噬菌体编码基因的富集。大肠微生物群编码了许多降解植物细胞壁成分的基因,而这些基因在回肠中不存在。与黏膜相关的回肠微生物群的细菌多样性高于肠腔,但与大肠黏膜的组成相似,这表明大多数肠道微生物可以与黏膜结合,并可能作为肠腔的接种物。抗生素喂养动物对微生物群的附带效应导致其与对照动物的微生物群产生差异,显著变化包括回肠中大肠杆菌数量增加、所有肠道部位的乳酸杆菌属增加,以及对未施用抗生素的耐药基因增加。表征不同肠道部位的差异代谢能力以及对扰动的反应将为改善肠道健康和食品安全的策略提供依据。